Hypertension | ACE Inhibitors and ARBs
Date Recorded: 10/6/2015
Last Day to Register: 6/30/2020
Instructional Hours: 1.00
Online Evaluation: Available 10/6/20156/30/2020
Post-Test?Yes (75% or better to pass)
*For on-demand programs with a post test, you must score 75% or higher and complete the online evaluation before the evaluation close date to receive credit.
Disclosure Statement: In accordance with the ACCME Essentials and Standards, anyone involved in planning or presenting this educational activity is required to disclose any relevant financial relationships with commercial interests in the healthcare industry. Presenters who incorporate information about off-label or investigational use of drugs or devices will be asked to disclose that information at the beginning of the presentation. 

Dr. Weber does have relevant financial relationships to disclose:
Speakers bureau - ARBOR - Hypertension
Speakers bureau - Novartis - Hypertension
Research grants - Lilly - Hypertension

Upstate AHEC Nursing Disclosure Information

Credit Statement: Upstate AHEC is an approved provider of Continuing Nursing Education by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Centers Commission on Accreditation.

Disclosure Statement: Upstate AHEC's conflict of interest policy requires faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations or materials.
The speaker(s) has signed a vested interest form declaring no conflict of interest in this activity.

Provision of this education activity by Upstate AHEC does not imply endorsement by Upstate AHEC, SCNA or ANCC of any commercial products displayed in conjunction with this activity.

Credit Requirements: To receive CE credit for completing this online course you must complete 100% of the material and 75% passing grade on Post-Test.

Method of participation: Audio lecture, post-test and evaluation

Expiration Date: 5/31/2017

Once you pass the post-test and complete the evaluation you will be able to print a certificate for verification of credit.
Description: ACE Inhibitors and ARBs therapy are key considerations on the current recommendations for the treatment and management of elevated blood pressure. Most effective therapies are being developed and current recommendations are associated high highest high blood pressure management. This SCHOOLS presentation describes the current recommendations in the use of ACEs and ARBs for hypertension treatment and the benefits associated with these classes of therapy. The original release date for this program was October 6th 2015 The original expiration date for this program's CME accreditation was May 31st 2017 The review date for this program's CME information was May 15th 2017 The new expiration date for this program's CME accreditation is June 30th 2020
Handouts: No handouts are currently available.

Accreditations and Pricing

AccreditationsConsortium MembersAll Others 
Physicians $0.00 $0.00
Medical University of South Carolina Office of CMEThe Medical University of South Carolina designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All Other Participants $0.00 $0.00
Area Health Education ConsortiumThis program provides 0.1 CEUs by South Carolina AHEC and meets South Carolina AHEC Best Practice Standards.
Non-MD/DO Providers That Require CME Certified Programs (PA's, PharmD's, etc.) $0.00 $0.00
Medical University of South Carolina Office of CMEThe Medical University of South Carolina will award 0.1 CEU(s) (equivalent to 1 contact hour(s)) for full time attendance. (1 contact hour equals .1 CEU)
Residents (MD/DO, DMD, PharmD)  $0.00
Area Health Education ConsortiumThis program provides .1 CEUs by SC AHEC and meets South Carolina AHEC Best Practice Standards.


Upon completion of this activity, participants will be able to:
Explain the benefits associated with the treatment of elevated blood pressure with RASS blockade as evidence of the results of recent clinical trials.
Describe the specific ACE and ARB agents with combinations and counter-indications.
Apply the current recommendations in the use of ACE and ARB to treat patients with high blood pressure.

Back to Program Listings